Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for ‘cosmetic’ reasons instead of diabetes and obesity

The news comes as rampant demand for the reputed “miracle drugs” leads to nationwide shortages.

Fortune

Dow Jones Futures Fall Amid Jobs Report As Fed Doubts Grow; Spot Bitcoin ETFs Loom

The major indexes held up Thursday with bullish action from many leading stocks. The December jobs report and spot Bitcoin ETF approvals loom.

Investors Business Daily

Eli Lilly Stock: Buy or Sell?

Eli Lilly's diversified portfolio and high demand for its weight-loss drugs have pushed it to the top of Wall Street's list of top pharma stocks for 2024. Is now the time to buy?

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Eli Lilly Beefs Up Its Weight-Loss Marketing Efforts With New Direct-To-Consumer Site

Eli Lilly stepped up its marketing efforts for weight-loss drugs Thursday, launching a new website. Eli Lilly stock fell a fraction.

Investors Business Daily

Eli Lilly says obesity drugs not for 'cosmetic' use amid digital-sales push

Eli Lilly is looking to deliver its anti-obesity treatments directly to consumers while warning against their use for 'cosmetic' weight loss.

The Street

Dow Jones Futures Rise After Market Losses; Cathie Wood Buys Tesla, Sells Bitcoin Stock Coinbase

The Nasdaq extended a losing streak. Cathie Wood bought Tesla stock and sold Bitcoin stock Coinbase.

Investors Business Daily

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Fall After Techs Skid To Start 2024; Celsius, Eli Lilly Flash Buy Signals

Big tech winners led Tuesday's skid. Weight loss plays Celsius and Eli Lilly flashed buy signals. Tesla and Microsoft held up.

Investors Business Daily

Eli Lilly, IBD Stock Of The Day, Strikes Bullish Pose After Closing A Key Buyout

Eli Lilly stock is Tuesday's IBD Stock Of The Day after the company wrapped its $1.4 billion takeover of Point Biopharma.

Investors Business Daily

Dow Jones Futures Fall To Start 2024; Tesla Deliveries Due As Rival Races Ahead

After a big 2023, the market rally looks strong heading into 2024. Tesla deliveries are due after key rivals reported.

Investors Business Daily

Which Mutual Funds Are Positioned Perfectly For 2024?

Positive economic events set a bullish storyline for investors in the best mutual funds in 2023.

Investors Business Daily

Will Eli Lilly's Emergency Diabetes Drug Give Amphastar Wings?

AMPH stock has doubled so far this year and is in a buy zone again. It earlier bought Eli Lilly's emergency diabetes drug which can drive future growth.

Investors Business Daily

Structure Plummets 43% After Trailing Lilly In Obesity Treatment

Structure's potential rival to Lilly in weight-loss drugs missed expectations on Monday, and GPCR stock took an absolute beating.

Investors Business Daily

Dow Jones Rallies After Surprise Jobless Claims, Retail Sales; Adobe Dives On Earnings

The Dow Jones rallied Thursday after a surprise drop in initial unemployment claims and U.S. retail sales. Adobe stock dived on earnings.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Falls After Cool Inflation Data; Tesla Slides On Recall; Fed Decision, Powell Up Next

The Dow Jones fell after more key inflation data Wednesday. The Fed's interest rate decision and Powell's comments are later in the day.

Investors Business Daily

Dow Jones Reverses On CPI Inflation Report; Tech Giant Oracle Dives On Earnings

The Dow Jones reversed higher Tuesday on the Consumer Price Index inflation report. Tech giant Oracle dived on weak sales results.

The Independent UK

Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study

‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says

Investors Business Daily

Dow Jones Futures: Magnificent Seven Stocks Slide; AI Giant Oracle Dives On Earnings; CPI Next

Dow Jones futures: The Magnificent Seven stocks tumbled Monday, with heavy losses in Nvidia and Tesla. The CPI inflation report is next.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Eli Lilly Stock Skids On A Key New Finding For Its Obesity Drug, Zepbound

Eli Lilly stock skidded Monday after a new study showed patients who stopped taking its weight-loss drug slowly regained weight over a year.

The Street

Eli Lilly slumps after disappointing Zepbound weight-loss-drug trial

Zepbound, which Eli Lilly had hoped would offset the slide in Trulicity sales, had mixed results in a major clinical trial.

Investors Business Daily

Dow Jones Falls; Apple Headlines 9 Best Stocks To Buy And Watch

The Dow Jones fell Monday ahead of this week's CPI and Fed meeting. Apple stock headlines 9 best stocks to buy and watch.

Investors Business Daily

Dow Jones Reverses Higher On Strong Jobs Report; LULU Stock Rallies On Earnings

The Dow Jones Industrial Average reversed Friday on a stronger-than-expected November jobs report. LULU stock rallied on earnings.

Investors Business Daily

Dow Jones Climbs After Jobless Claims Rise; Google Stock Surges After Gemini AI Model

The Dow Jones climbed Thursday after the Labor Department's jobless claims. Google stock surged after unveiling its Gemini AI model.

Inverse

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

Investors Business Daily

Amphastar, Stock Of The Day, Breaks Out As It Sees Upside From Eli Lilly Deal

Amphastar is IBD Stock Of The Day as the biotech stock revs up marketing of Baqsimi, a drug purchased this year from Eli Lilly.

1 … 12 13 14 15

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.